Cite
HARVARD Citation
Zhu, C. et al. (2014). Adenosine A2A receptor antagonist istradefylline 20 versus 40 mg/day as augmentation for Parkinson's disease: a meta-analysis. Neurological research. pp. 1028-1034. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhu, C. et al. (2014). Adenosine A2A receptor antagonist istradefylline 20 versus 40 mg/day as augmentation for Parkinson's disease: a meta-analysis. Neurological research. pp. 1028-1034. [Online].